However, MDR-induced upregulation of TGF-β and SMAD4 expression was significantly suppressed by PZH treatment, suggesting that PZH suppresses TGF-β pathway in drug-resistant colorectal cancer cells. This evidence concerns the gene TGFB1 and colorectal cancer.